Next-Generation Sequencing: Role in Gynecologic Cancers

Area of Science:

• Oncology
• Genomics
• Molecular Biology

Background:

• Next-generation sequencing (NGS) is revolutionizing solid tumor analysis.
• Genomic alterations in gynecologic cancers are increasingly identified through NGS.
• Understanding these alterations is crucial for developing targeted therapies.

Purpose of the Study:

• To review the impact of NGS on the molecular profiling of gynecologic cancers.
• To highlight how NGS has expanded the understanding of gynecologic malignancy genomics.
• To discuss the role of NGS in identifying mutations, reclassifying tumors, and determining treatment resistance.

Main Methods:

• Review of current literature on NGS applications in gynecologic oncology.
• Analysis of studies identifying germline and somatic mutations using NGS.
• Examination of NGS-driven therapeutic strategies and their clinical utility.

Main Results:

• NGS has unveiled numerous previously unrecognized genomic alterations in gynecologic cancers.
• Identification of germline and somatic mutations aids in understanding cancer development.
• NGS facilitates the development of targeted therapies based on actionable molecular aberrations.
• NGS contributes to tumor reclassification and understanding treatment resistance mechanisms.

Conclusions:

• NGS significantly enhances the molecular understanding of gynecologic cancers.
• It enables more rational therapeutic strategies, expanding options for targeted treatments.
• Further research is needed to address the cost and clinical utility of NGS in routine practice.
• NGS is a powerful tool for advancing the diagnosis and treatment of ovarian, endometrial, cervical, and vulvar cancers.